The quest for the function of BPAG1, a major hemidesmosomal protein of skin keratinocytes, has led to the discovery of a group of protein isoforms derived from the same genomic locus that are involved in organizing and integrating cytoskeletal networks in sensory neurons.
This story begins with the epidermis, a stratified squamous epithelium located at the skin surface that acts as the primary determinant of the skin's vital barrier function. Epidermal keratinocytes achieve a flexible and highly resilient cytoarchitecture in part by building a prominent cytoskeletal framework composed primarily of keratin-based intermediate filaments. Intermediate filaments are long and flexible, 10-12 nm diameter, and are ubiquitous in the cells of higher multicellular eukaryotes. They can be assembled from more than 50 distinct proteins, which are heterogeneous in several respects but which can be grouped into distinct types on the basis of gene structure and sequence homology [3] .
Type I-IV intermediate filament proteins localize to the cytoplasm of specific cell types, where they are organized into a filamentous network that spans nearly the entire cell, independent of the cell's degree of spatial differentiation -whether a lymphocyte or a neuron. The intermediate filaments of epithelial cells are co-polymers of type I and type II keratins that extend radially and in a non-polarized fashion from the nucleus to the plasma membrane, where they interact with macromolecular complexes that mediate cell-cell and cell-matrix adhesion. In stratified epithelia, these complexes are desmosomes, which form cell-cell junctions, and hemidesmosomes, integrin-based mediators of the attachment of basal keratinocytes to the basal lamina. Given their anchorage at hundreds of points of contact, keratin intermediate filaments seem to be integrated within a supracellular network that is likely to underlie the vital properties of resilience and flexibility in stratified epithelia. The discovery that inherited mutations that affect specific keratins, and thereby compromise keratin filament integrity, cause a variety of inherited skin blistering diseases established that an integral intermediate filament network is indeed an essential determinant of the ability of the epidermis to cope with the mechanical stresses it routinely endures (see [4] ).
BPAG1, the bullous pemphigoid antigen 1, is a 230 kDa protein that was initially characterized as a major autoantigen in patients suffering from bullous pemphigoid [5] . This late-onset bullous disease affects the skin and mucous membranes, and is characterized by the presence of circulating autoantibodies directed against hemidesmosomeassociated antigens. Immunoelectron microscopy showed that BPAG1 localizes mainly to the cytoplasmic 'plaque' domain of hemidesmosomes, at the site of keratin intermediate filament anchorage [5] . The tail domain of BPAG1 is homologous to that of desmoplakin, a major component of the cytoplasmic domain of desmosomes, and to that of plectin, an intermediate-filament binding protein present in both desmosomes and hemidesmosomes. Given that desmoplakin and plectin tails can both associate with keratin filaments in vivo and in vitro [6] [7] [8] , it seemed likely that BPAG1 could be directly involved in linking keratincontaining intermediate filaments to hemidesmosomes.
To test this notion, Guo et al. [1] introduced a null mutation in the mouse BPAG1 gene. Consistent with the postulate, absence of BPAG1 protein in basal keratinocytes resulted in the loss of the inner cytoplasmic plaque and 'severing' of keratin filaments at hemidesmosomes. The BPAG1-null mice displayed a typical blistering phenotype upon incident mechanical trauma to the skin, and cleavage of the epidermis took place in a narrow region of cytoplasm beneath the keratinocyte plasma membrane domain abutting the basal lamina [1] . This experiment thus demonstrated an essential role for BPAG1 in anchoring keratin intermediate filaments at hemidesmosomes, and showed this interaction to be essential for the structural integrity of stratified epithelia such as the epidermis, tongue and oral mucosa.
Most unexpectedly, the BPAG1-null mice also showed severe neurodegeneration and dystonia typical of dystonia musculorum (dt/dt) mice. In various strains of dt/dt as well as in BPAG1-null mice, a selective sensory neuropathy leads to a progressive deterioration of motor function, starting at 7-10 days postnatally and culminating in death a few weeks later (see [1, 9] ). Yet the BPAG1 protein, as conceived of by epithelial biologists, does not occur in nervous tissue. On the other hand, Guo et al. [1] found the BPAG1 protein to be missing in the stratified epithelia of one of two spontaneous dt/dt strains they examined (dt/dt alb ). How is this possible? A solution to the paradox was provided by Kothary and his colleagues [9] , who exploited a line of transgenic mice, tg 4 , which carry a large insertional mutation at the dt locus, to characterize the corresponding wildtype gene. They isolated partial sequences for two mRNA transcripts that span the tg 4 deletion site and contain sequences corresponding to exon 2 of the 'epithelial BPAG1 gene' (which has a total of 22 exons; see [10] ).
As might be predicted from the dt phenotype, the tg 4 -spanning BPAG1 transcripts are present in the dorsal root and trigeminal ganglia, as detected by in situ hybridization (see also [2] ). From the available data on the 'epithelial BPAG gene' [10] and their own results, Khotary and colleagues [9] proposed a model that accounts for the production of neuron-specific and epithelium-specific transcripts from a single gene, the dt/BPAG1 locus, as a result of the use of alternative promoters and a combination of isoformspecific and shared exons (Fig. 1) . In addition, they recognized the presence of a potential actin-binding domain (ABD) in the amino-terminal segment of the two BPAG1 neuronal isoforms; this domain is predicted to be missing in the epithelial isoform. Fuchs and colleagues [2] recently completed the cloning and extended the characterization of the neuronal-specific BPAG1 cDNA sequences; they proposed the designation BPAG1e and BPAG1n for the epithelial and neuronal isoforms, respectively. The proposed transcript map shown in Figure 1 accounts for the phenotypes associated with the BPAG1-null mutation and the various strains of dt/dt mice [1, 2, 9] .
The presence of a potential actin-binding domain in both BPAG1n isoforms leads to the prediction that they could mediate an interaction between neuronal intermediate filaments (neurofilaments) and actin microfilaments in the subset of sensory neurons expressing them. This prediction is supported by several lines of evidence, not least being the disruption of neurofilaments in the axoplasm of the BPAG1n-expressing sensory neurons of dt/dt mice (see [2, 9] and references therein). The Fuchs laboratory [2] provided compelling evidence in support of the 'linker' hypothesis in an elegant set of follow-up studies. They showed that transfection of the amino-terminal domain characteristic of BPAG1n isoforms (containing the ABD motif) in human SCC13 keratinocytes results in its colocalization with endogenous microfilaments, and that this interaction can be reproduced in vitro using purified components. They also showed that the tail domain of BPAG1e/n colocalizes with endogenous keratin filaments in transfected keratinocytes, and that it colocalizes with neurofilaments when co-transfected with neurofilament cDNAs in a SW13 cell clone totally lacking in intermediate filaments. Finally, they showed that co-transfection of a full-length BPAG1n cDNA and neurofilament cDNAs in intermediate-filament-negative SW13 cells resulted in frequent co-alignment of the immunofluorescence signals for BPAG1, neurofilaments and microfilaments. (a) Schematic representation of the proposed organization of the BPAG1 genomic locus (adapted from [9] ). Two tissue-specific promoters direct the expression of neuron-specific (BPAG1n1, BPAG1n2) and epithelium-specific (BPAG1e) isoform mRNAs. Two neuronal isoforms are predicted to arise from the alternative splicing of a precursor mRNA. (b) Schematic representation of the BPAG1 protein isoforms (adapted from [2] ). Regions are color-coded to highlight their origin with respect to the genomic locus: green boxes, neuronal isoformspecific coding sequences; yellow, actin-binding domain (ABD), which is also specific to the neuronal isoforms; blue, sequences corresponding to exon 1 of the BPAG1e coding unit and specific for the epithelial isoform; pink, sequences corresponding to exon 2 of the BPAG1e coding unit, which mark the beginning of the shared sequences between all isoforms; orange, coding sequences shared by all isoforms and containing the intermediate-filament binding site(s). An additional isoform showing a distinct head domain structure has been described (see [2] ). These studies demonstrated that, in a living cell context, BPAG1n can not only bind to microfilaments and neurofilaments simultaneously, but also force their merging into an integrated structure [2] . The BPAG1n isoforms may thus contribute to defining the cytoarchitecture of the axoplasm by tethering parallel arrays of densely packed neurofilaments to the microfilament cytoskeleton. If proven, this would imply that the neuronal and epithelial isoforms of BPAG1 both contribute directly to the organization of an integrated cytoskeleton adapted to the structural and functional requirements of the cell types in which they are each expressed. Meanwhile, the functional implications of a neurofilament-microfilament interaction for the biology of sensory neurons need to be further investigated. Moreover, whether this interaction occurs in all type of neurons, and if so, the identity of the connector protein(s) that could mediate an intermediate filament-microfilament interaction in the extensive population of neurons that apparently lack BPAG1, are now important issues open for investigation.
The recent work from Fuchs and colleagues reinforces the notion that BPAG1e/n, desmoplakin and plectin belong to a family of structurally and functionally related proteins [11] that serve as linkers between cytoplasmic intermediate filaments and various types of cytoskeletal and adhesion-mediating protein polymers. Plectin is unique among cytoskeletal connector proteins because it displays biochemical properties that potentially enable it to profoundly affect the organization of all three major types of cytoplasmic filaments -intermediate filaments, microfilaments and microtubules (see [12] [13] [14] ). Recent studies on plectin yielded additional evidence of its relatedness to BPAG1. For instance, the amino-terminus of plectin features an amino-acid sequence highly homologous to the actin-binding domain of BPAG1n [2] , and Wiche and colleagues [12] provided ultrastructural evidence for the existence of plectin-based cross-bridges between vimentin-containing intermediate filaments and microfilaments in rat C6 glioma cells. The same group recently identified a 50 amino-acid segment in the tail domain of plectin that is capable of binding vimentin and keratin filaments in vitro and in vivo [13] . This segment features a basic motif at its amino-terminal end that is not only essential for intermediate filament binding but also capable of acting as a nuclear localization signal (the significance of this surprising finding remains unclear). Wiche and colleagues [13] also pointed out that they obtained evidence for additional intermediate filamentbinding sites on the plectin molecule. Whether plectin, BPAG1e/n and desmoplakin bind intermediate filaments by the same mechanism(s) remains to be determined.
At another level, a frameshift mutation in the coding sequence of plectin was recently shown to cause epidermolysis bullosa (EB) with muscular dystrophy [15] ; EB is the collective name for a group of inherited skin bullous diseases (see [4] ). It is likely that mutations in the plectin gene underlie yet another form of EB, called EBS-Ogna, as both map to 8q24 [14] . Given the similarities at multiple levels, including their ability to bind both intermediate filaments and microfilaments, their subcellular localization and their association with related types of human disease, it seems very likely that the plectin and BPAG1 isoforms perform related functions in vivo.
The discovery of multiple BPAG1 isoforms arising from the alternative, tissue-specific splicing of a precursor mRNA provides a further similarity to plectin and desmoplakin. Two desmoplakin isoforms have been described that are predicted to arise from the alternative splicing of 5′ exons in a precursor mRNA [16] , and evidence that a similar situation may hold for plectin has recently emerged [14, 15] . If confirmed, the existence of alternative splice isoforms for plectin would provide a likely explanation for some conflicting data concerning the sequence and subcellular localization of this protein.
The cytoskeleton forms an intricate three-dimensional web that is an intrinsic determinant of the functional organization of eukaryotic cells. Ever since the first model attempting to merge the three major types of cytoplasmic filaments (microfilaments, microtubules and intermediate filaments) into an integrated three-dimensional structure [17] , direct evidence supporting such an integrated cytoskeleton and, in particular, information relative to the molecules responsible for integration have proven elusive. The recent results with plectin and BPAG1 isoforms have finally yielded proof of the existence and essential nature of such 'missing links'. Continued studies of BPAG1, plectin, desmoplakin and related molecules will undoubtedly provide further evidence of their coalition as a group of structurally and functionally related proteins responsible for the dynamic organization of an integrated cytoskeleton. Such studies are also likely to provide clues as to how the corresponding genes may have evolved in parallel with the intermediate filament gene family (and by extension, other cytoskeletal proteins) to tailor the cytoskeleton for the general as well as the specialized needs of differentiated cell types.
